ClinicalTrials.govpublic full text
Adebrelimab With Famitinib and Chemotherapy as Neoadjuvant Therapy for ESCC
esophageal squamous cell carcinoma, escc, adebrelimab, famitinib, neoadjuvant, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1033626
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.